- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eden Research (EDENE)
The Eden Research share price today is 3.50, view LON EDENE stock exchange data. Track the latest Eden Research share price with real-time updates on EDENE stock performance including market cap, day range, 52-week range and dividend yield. Access EDENE charts, earnings dates and analyst estimates to support your investment decisions.
London
Currency in GBP
3.50
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.40
3.60
52 wk Range
1.96
5.00
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.403.60
52 wk Range
1.965.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
EDENE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Eden Research to present full year results on May 14
- Investing.com
- Eden Research launches £500,000 retail share offer
- Investing.com
- Eden Research launches £500,000 retail share offer
- Investing.com
- Eden Research to present full year results on May 14
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
17-09-2025
EPS / Forecast
-- / --
Revenue / Forecast
1.2M / --
Compare EDENE to Peers and Sector
Metrics to compare | EDENE | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipEDENEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.1x | 11.6x | 4.2x | |
PEG Ratio | 0.27 | 0.01 | 0.00 | |
Price/Book | 2.7x | 1.7x | 1.6x | |
Price / LTM Sales | 7.9x | 2.1x | 1.4x | |
Upside (Analyst Target) | - | 30.3% | 27.3% | |
Fair Value Upside | Unlock | 8.2% | −1.7% | Unlock |
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, bio-control, parasite treatments, and insect sprays. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Eden Research (EDENE) Share Price Today?
The Eden Research share price today is 3.50.
What is the current Eden Research (EDENE) share price and day range?
As of 05-05-2026, the Eden Research share price is 3.50, with a previous close of 3.50. The share price has ranged from 3.40 to 3.60 today, while the 52-week range spans from 1.96 to 5.00.
What Is the Eden Research Market Cap?
As of today, Eden Research market cap is 28.20M.
What Is the Eden Research (EDENE) Share Price Target?
The average 12-month share price target for Eden Research is 20.00, with a high estimate of 20 and a low estimate of 20. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +471.43% Upside potential.
What Is Eden Research's Earnings Per Share (TTM)?
The Eden Research EPS (TTM) is -0.00.
When Is the Next Eden Research Earnings Date?
Eden Research will release its next earnings report on 12-05-2026.
From a Technical Analysis Perspective, Is EDENE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Eden Research Trade On?
Eden Research is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Eden Research?
The stock symbol for Eden Research is "EDENE."
How Many Times Has Eden Research Stock Split?
Eden Research has split 1 times.
How Many Employees Does Eden Research Have?
Eden Research has 23 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.